Cargando…
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
BACKGROUND: The risk of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) infection and clinical outcomes of coronavirus disease (COVID‐19) in inflammatory bowel disease are unclear. METHODS: We searched PubMed and Embase with the keywords: inflammatory bowel disease, Crohn's...
Autores principales: | Singh, Anupam Kumar, Jena, Anuraag, Kumar‐M, Praveen, Sharma, Vishal, Sebastian, Shaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250629/ https://www.ncbi.nlm.nih.gov/pubmed/33210980 http://dx.doi.org/10.1177/2050640620972602 |
Ejemplares similares
-
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Singh, Anupam K., et al.
Publicado: (2022) -
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021) -
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
por: James, Deepak, et al.
Publicado: (2022) -
Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
por: Jena, Anuraag, et al.
Publicado: (2020) -
Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis
por: Jena, Anuraag, et al.
Publicado: (2022)